NCT04651452View on ClinicalTrials.gov

Writing Interventions in Breast Cancer Patients Taking Aromatase Inhibitors

NAActive, not recruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Breast Cancer
Interventions
BEHAVIORAL

Value Affirmation

Participants will complete writing tasks regarding their personal values.

BEHAVIORAL

Reflective Journaling

Participants will complete writing tasks regarding their least important values and discuss why they may be important to others. They will also describe aspects of daily life.

Trial Locations (1)

15213

Carnegie Mellon University, Pittsburgh

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Carnegie Mellon University

OTHER